Colette DeJong - Concepedia

Author

Colette DeJong

University of California, San Francisco ORCID

Also Known As

Bernard Hengesbaugh, COLETTE DEJONG, Colette DeJong, Colette Dejong, Elizabeth Adler, James Madara, Jennifer Claytor, Joseph Ross, San Francisco

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Lee University Pacific Health Research and Education Institute University of Hawaiʻi at Mānoa Harvard University

About

Colette DeJong is an author at University of California, San Francisco specializing in public health, medicine, and health services research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	196
2	Public Health	7	7	196
3	Engineering	1	1	44
4	Nursing	1	1	19
5	Diabetes	1	1	41

Colette DeJong

Publications

941

Citations

H-Index

Page 1

	Year	Citations
Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries Colette DeJong, Thomas Aguilar, Chien‐Wen Tseng, JAMA Internal Medicine	2016	492
Validation of Prediction Models for Critical Care Outcomes Using Natural Language Processing of Electronic Health Record Data Ben J. Marafino, Miran Park, Jason M. Davies, JAMA Network Open	2018	118
Variation in Quality of Urgent Health Care Provided During Commercial Virtual Visits Adam J. Schoenfeld, Jason M. Davies, Ben J. Marafino, JAMA Internal Medicine	2016	68
Incorporating a New Technology While Doing No Harm, Virtually Colette DeJong, Catherine R. Lucey, R. Adams Dudley JAMA New TechnologyEngineeringDesignUser ExperienceTechnology Change	2015	44
Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D Colette DeJong, Camlyn Masuda, Randi Chen, JAMA Internal Medicine Diabetes ManagementPrimary CareHealth PolicyHealth EconomicsDiabetes	2020	41
The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease Dhruv S. Kazi, Colette DeJong, Randi Chen, Journal of the American College of Cardiology Health Insurance ReformHealth PolicyHealth EconomicsCardiovascular DiseaseHealth Insurance	2023	34
An Ethical Framework for Allocating Scarce Inpatient Medications for COVID-19 in the US Colette DeJong, Alice Hm Chen, Bernard Lo JAMA Medical EthicsEthical FrameworkHealth PolicyTreatment And PreventionHealthcare Provision	2020	32
Medicare Part D Plans’ Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease Chien‐Wen Tseng, Jinoos Yazdany, R. Adams Dudley, JAMA Internal Medicine ’ CoveragePulmonary CareHealth PolicyAcute RescueHealth Insurance	2017	30
Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans Dhruv S. Kazi, Christine Y. Lu, Grace A. Lin, JAMA Cardiology Disease ProgressionPharmacotherapyGregg C. FonarowPathophysiologyDisease Physiology	2017	26
Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States Kosuke Inoue, José F. Figueroa, Colette DeJong, Circulation Cardiovascular Quality and Outcomes	2021	23

Page 1